z-logo
open-access-imgOpen Access
Chryseobacterium indologenesSepticemia in an Infant
Author(s) -
Türkan Aydın Teke,
Fatma Nur Öz,
Özge Metin,
Gülsüm İclal Bayhan,
Zeynep Gökçe Gayretli Aydın,
Melahat Melek Oğuz,
Gönül Tanır
Publication year - 2014
Publication title -
case reports in infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2090-6625
pISSN - 2090-6633
DOI - 10.1155/2014/270521
Subject(s) - chryseobacterium , medicine , antimicrobial , trimethoprim , sulfamethoxazole , pediatrics , antibiotics , intensive care medicine , microbiology and biotechnology , bacteria , biology , genetics , 16s ribosomal rna
Chryseobacterium indologenes is a rare cause of infection in children. The organism causes infections mostly in hospitalised patients with severe underlying diseases. The choice of an effective drug for the treatment of infections due to C. indologenes is difficult as the organism has a limited spectrum of antimicrobial sensitivity. We present a case of nosocomial septicemia caused by C. indologenes in an infant with congenital heart disease who was successfully treated with trimethoprim sulfamethoxazole and also reviewed fourteen additional cases of C. indologenes infections reported in the English literature in this report.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom